Literature DB >> 2433462

Functional and antigenic domains of the matrix (M1) protein of influenza A virus.

Z P Ye, R Pal, J W Fox, R R Wagner.   

Abstract

The membrane- and ribonucleocapsid (RNP)-binding domains of the matrix (M1) protein of influenza A virus (WSN strain) were partially mapped and characterized by reactivity with monoclonal antibodies (MAb) as well as by proteolytic cleavages and amino acid sequencing of the resulting peptides. Of two peptides formed by formic acid hydrolysis, a 9-kilodalton fragment at the amino-terminal third of the M1 protein was recognized by MAb M2-1C6 (to epitope 1), and a 15-kilodalton fragment at the carboxy-terminal two-thirds was recognized by MAb 289/4 (to epitope 2). Partial cleavage by staphylococcal V8 protease gave rise to a 16-kilodalton peptide, mapping to amino acid 8, which was recognized by MAbs to all three epitopes but rather weakly by MAb 904/6 to epitope 3. These studies suggest that epitope 1 of the M1 protein resides between amino acids 8 and 89, whereas epitopes 2 and possibly 3 are located between amino acids 89 and 141 or somewhat more carboxy distal. The intact M1 protein and its N-terminal 9- and 10-kilodalton peptides generated by formic acid or V8 protease cleavage, respectively, reconstituted with dipalmitoylphosphatidylcholine vesicles, but these N-terminal peptides had little effect on in vitro transcription of the RNP core. In sharp contrast, both intact M1 protein and the C-terminal 15-kilodalton formic acid fragment were able to inhibit viral transcription markedly. Moreover, MAb 289/4 (to epitope 2) reversed this inhibited transcription significantly. These studies suggest that the lipid-binding domain of the M1 protein is located within the amino-terminal third, whereas the site involved in the interaction of the M1 protein with RNP cores is located within the carboxy-terminal two-thirds.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433462      PMCID: PMC253942     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product.

Authors:  R Pal; B W Grinnell; R M Snyder; J R Wiener; W A Volk; R R Wagner
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

3.  Cleavage at aspartyl-prolyl bonds.

Authors: 
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

4.  The matrix (M) protein of vesicular stomatitis virus regulates transcription.

Authors:  G M Clinton; S P Little; F S Hagen; A S Huang
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

5.  Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus.

Authors:  A R Carroll; R R Wagner
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

6.  The membrane protein of influenza virus: extraction from virus and infected cell with acidic chloroform-methanol.

Authors:  A Gregoriades
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

7.  The structure of influenza virus. II. A model based on the morphology and composition of subviral particles.

Authors:  I T Schulze
Journal:  Virology       Date:  1972-01       Impact factor: 3.616

8.  Further observations on the structure of influenza viruses A and C.

Authors:  K Apostolov; T H Flewett
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

9.  Interaction of influenza virus proteins with planar bilayer lipid membranes. I. Characterization of their adsorption and incorporation into lipid bilayers.

Authors:  S El Karadaghi; J A Zakomirdin; C Shimane; D J Bucher; V A Tverdislov; I G Kharitonenkov
Journal:  Biochim Biophys Acta       Date:  1984-12-05

10.  Antigenic characterization of influenza A virus matrix protein with monoclonal antibodies.

Authors:  K L van Wyke; J W Yewdell; L J Reck; B R Murphy
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

View more
  48 in total

1.  The packaging signal of influenza viral RNA molecules.

Authors:  S Tchatalbachev; R Flick; G Hobom
Journal:  RNA       Date:  2001-07       Impact factor: 4.942

2.  Restriction of viral replication by mutation of the influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells.

Authors:  P G Hughey; R W Compans; S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Characterization of the antiviral activity for influenza viruses M1 zinc finger peptides.

Authors:  Yongjin Wang; Huihui Xiao; Nannan Wu; Huiling Shi; Hongwei Xu; Lichen Zhou; Xu-Guang Xi; Tianhou Wang; Xiaoming Wang
Journal:  Curr Microbiol       Date:  2010-06-05       Impact factor: 2.188

5.  Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity.

Authors:  D A Simpson; R A Lamb
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

6.  Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus.

Authors:  G Whittaker; I Kemler; A Helenius
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  Introduction of a temperature-sensitive phenotype into influenza A/WSN/33 virus by altering the basic amino acid domain of influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Rabies virus M protein expressed in Escherichia coli and its regulatory role in virion-associated transcriptase activity.

Authors:  Y Ito; A Nishizono; K Mannen; K Hiramatsu; K Mifune
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype.

Authors:  Steven A Rubin; Georgios Amexis; Mikhail Pletnikov; Zongqi Li; Jacqueline Vanderzanden; Jeremy Mauldin; Christian Sauder; Tahir Malik; Konstantin Chumakov; Kathryn M Carbone
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies.

Authors:  D Bucher; S Popple; M Baer; A Mikhail; Y F Gong; C Whitaker; E Paoletti; A Judd
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.